je.st
news
ImStar Therapeutics Selects Lead Drug Candidate For ALS
2013-12-04 04:16:22| drugdiscoveryonline News Articles
ImStar Therapeutics today announced the selection of IMS-088 as its lead drug candidate for the treatment of Amyotrophic Lateral Sclerosis (ALS). The company is preparing to initiate IND-enabling studies in the second half of 2014
Tags: als
lead
drug
candidate
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||